400 related articles for article (PubMed ID: 28780238)
21. Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.
Schwinger W; Sovinz P; Benesch M; Lackner H; Seidel M; Strenger V; Sperl D; Raicht A; Brunner-Krainz M; Paschke E; Plecko B; Urban C
Pediatr Hematol Oncol; 2014 Nov; 31(8):723-30. PubMed ID: 25116402
[TBL] [Abstract][Full Text] [Related]
22. A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Devillier R; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Harbi S; Granata A; D'Incan E; Coso D; Chabannon C; Picard C; Etienne A; Calmels B; Schiano JM; Lemarie C; Stoppa AM; Bouabdallah R; Vey N; Blaise D
Am J Hematol; 2014 Jan; 89(1):83-7. PubMed ID: 24108528
[TBL] [Abstract][Full Text] [Related]
23. Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Gonzalez-Vicent M; Perez A; Abad L; Sevilla J; Ramirez M; Diaz MA
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e85-90. PubMed ID: 20216238
[TBL] [Abstract][Full Text] [Related]
24. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ
Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M
Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621
[TBL] [Abstract][Full Text] [Related]
26. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
[TBL] [Abstract][Full Text] [Related]
27. Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
Bethge WA; Eyrich M; Mielke S; Meisel R; Niederwieser D; Schlegel PG; Schulz A; Greil J; Bunjes D; Brecht A; Kuball J; Schumm M; Vucinic V; Wiesneth M; Bonig H; Westinga K; Biedermann S; Holtkamp S; Karitzky S; Malchow M; Siewert C; Handgretinger R; Lang P
Bone Marrow Transplant; 2022 Mar; 57(3):423-430. PubMed ID: 34952929
[TBL] [Abstract][Full Text] [Related]
28. Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
Law J; Cowan MJ; Dvorak CC; Musick L; Long-Boyle JR; Baxter-Lowe LA; Horn B
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1656-63. PubMed ID: 22609040
[TBL] [Abstract][Full Text] [Related]
29. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
30. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
[TBL] [Abstract][Full Text] [Related]
31. Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia.
Bertaina A; Zecca M; Buldini B; Sacchi N; Algeri M; Saglio F; Perotti C; Gallina AM; Bertaina V; Lanino E; Prete A; Barberi W; Tumino M; Favre C; Cesaro S; Del Bufalo F; Ripaldi M; Boghen S; Casazza G; Rabusin M; Balduzzi A; Fagioli F; Pagliara D; Locatelli F
Blood; 2018 Dec; 132(24):2594-2607. PubMed ID: 30348653
[TBL] [Abstract][Full Text] [Related]
32. T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity.
Lum SH; Greener S; Perez-Heras I; Drozdov D; Payne RP; Watson H; Carruthers K; January R; Nademi Z; Owens S; Williams E; Waugh S; Burton-Fanning S; Leahy TR; Cant A; Abinun M; Flood T; Hambleton S; Gennery AR; Slatter M
Blood Adv; 2022 Feb; 6(4):1319-1328. PubMed ID: 34972212
[TBL] [Abstract][Full Text] [Related]
33. αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
Shelikhova L; Ilushina M; Shekhovtsova Z; Shasheleva D; Khismatullina R; Kurnikova E; Pershin D; Balashov D; Radygina S; Trakhtman P; Kalinina I; Muzalevskii Y; Kazachenok A; Zaharova V; Brilliantova V; Olshanskaya Y; Panferova A; Zerkalenkova E; Baidildina D; Novichkova G; Rumyantsev A; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2019 May; 25(5):e179-e182. PubMed ID: 30677509
[TBL] [Abstract][Full Text] [Related]
34. Control of graft-versus-host disease with rabbit anti-thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19-depleted graft transplantation for leukemia in children: a single-center retrospective analysis of two GVHD-prophylaxis regimens.
Shekhovtsova Z; Shelikhova L; Balashov D; Zakharova V; Ilushina M; Voronin K; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Novichkova G; Maschan A; Maschan M
Pediatr Transplant; 2020 Feb; 24(1):e13594. PubMed ID: 31680369
[TBL] [Abstract][Full Text] [Related]
35. CD3
Oved JH; Wang Y; Barrett DM; Levy EM; Huang Y; Monos DS; Grupp SA; Bunin NJ; Olson TS
Biol Blood Marrow Transplant; 2019 Mar; 25(3):549-555. PubMed ID: 30312755
[TBL] [Abstract][Full Text] [Related]
36. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
[TBL] [Abstract][Full Text] [Related]
37. Total body irradiation-free haploidentical peripheral blood stem cell transplantation compared to related and unrelated donor transplantation in pediatrics with acute lymphoblastic leukemia.
Mardani M; Behfar M; Jafari L; Mohseni R; Naji P; Salajegheh P; Donyadideh G; Hamidieh AA
Pediatr Blood Cancer; 2023 May; 70(5):e30255. PubMed ID: 36815626
[TBL] [Abstract][Full Text] [Related]
38. HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties.
Giardino S; Eikema DJ; Piepenbroek B; Algeri M; Ayas M; Faraci M; Tbakhi A; Zecca M; Essa M; Neven B; Bertrand Y; Kharya G; Bykova T; Lawson S; Petrini M; Mohseny A; Rialland F; James B; Colita A; Fahd M; Cesaro S; Schulz A; Kleinschmidt K; Kałwak K; Corbacioglu S; Dufour C; Risitano A; de Latour RP
Am J Hematol; 2024 Jun; 99(6):1066-1076. PubMed ID: 38497679
[TBL] [Abstract][Full Text] [Related]
39. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
40. Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.
Lee KH; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Hwang HJ; Jung AR; Kim SH; Yun SC; Shin HJ
Blood; 2011 Sep; 118(9):2609-17. PubMed ID: 21715313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
